Brief: Solasia, Nippon Kayaku Announce License Agreement In Japan For New Drug Candidate Darinaparsin
Oct 26 (Reuters) - Nippon Kayaku Co Ltd 4272.T :
* SOLASIA AND NIPPON KAYAKU ANNOUNCE LICENSE AGREEMENT IN
JAPAN
FOR NEW DRUG CANDIDATE DARINAPARSIN (SP-02)
Source text for Eikon: ID:nBw7vKYL7a
Further company coverage: 4272.T
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Nippon Kayaku Co
See all newsBrief: Silchester Cuts Stake In Nippon Kayaku To 4.68% From 5.76%, Filing Shows
Brief: Silchester Cuts Stake In Nippon Kayaku Co To 4.68% From 5.76%, Filing Shows
To Buy Up To 13,000,000 Own Shares, 8.75% Of Outstanding Shares
Table: Nippon Kayaku -2025/26 group results
Table: Nippon Kayaku -2025/26 parent results